350 related articles for article (PubMed ID: 18818766)
21. The potential of class 3 semaphorins as both targets and therapeutics in cancer.
Mishra R; Kumar D; Tomar D; Chakraborty G; Kumar S; Kundu GC
Expert Opin Ther Targets; 2015 Mar; 19(3):427-42. PubMed ID: 25434284
[TBL] [Abstract][Full Text] [Related]
22. Expression of class 3 semaphorins and their receptors in human breast neoplasia.
Staton CA; Shaw LA; Valluru M; Hoh L; Koay I; Cross SS; Reed MW; Brown NJ
Histopathology; 2011 Aug; 59(2):274-82. PubMed ID: 21884206
[TBL] [Abstract][Full Text] [Related]
23. Semaphorin signaling in vascular and tumor biology.
Neufeld G; Lange T; Varshavsky A; Kessler O
Adv Exp Med Biol; 2007; 600():118-31. PubMed ID: 17607951
[TBL] [Abstract][Full Text] [Related]
24. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.
Rieger J; Wick W; Weller M
Glia; 2003 Jun; 42(4):379-89. PubMed ID: 12730958
[TBL] [Abstract][Full Text] [Related]
25. Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.
Yoshikawa Y; Sato A; Tsujimura T; Morinaga T; Fukuoka K; Yamada S; Murakami A; Kondo N; Matsumoto S; Okumura Y; Tanaka F; Hasegawa S; Hashimoto-Tamaoki T; Nakano T
Int J Oncol; 2011 Dec; 39(6):1365-74. PubMed ID: 21842119
[TBL] [Abstract][Full Text] [Related]
26. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.
Nakayama H; Huang L; Kelly RP; Oudenaarden CR; Dagher A; Hofmann NA; Moses MA; Bischoff J; Klagsbrun M
Biochem Biophys Res Commun; 2015 Aug; 464(1):126-32. PubMed ID: 26086095
[TBL] [Abstract][Full Text] [Related]
27. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L
EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010
[TBL] [Abstract][Full Text] [Related]
28. Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis.
Yang WJ; Hu J; Uemura A; Tetzlaff F; Augustin HG; Fischer A
EMBO Mol Med; 2015 Oct; 7(10):1267-84. PubMed ID: 26194913
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
Bender RJ; Mac Gabhann F
BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
[TBL] [Abstract][Full Text] [Related]
31. Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
Karayan-Tapon L; Wager M; Guilhot J; Levillain P; Marquant C; Clarhaut J; Potiron V; Roche J
Br J Cancer; 2008 Oct; 99(7):1153-60. PubMed ID: 18781179
[TBL] [Abstract][Full Text] [Related]
32. Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis.
Avouac J; Pezet S; Vandebeuque E; Orvain C; Gonzalez V; Marin G; Mouterde G; Daïen C; Allanore Y
Arthritis Rheumatol; 2021 Sep; 73(9):1579-1588. PubMed ID: 33605067
[TBL] [Abstract][Full Text] [Related]
33. Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
Maejima R; Tamai K; Shiroki T; Yokoyama M; Shibuya R; Nakamura M; Yamaguchi K; Abue M; Oikawa T; Noguchi T; Miura K; Fujiya T; Sato I; Iijima K; Shimosegawa T; Tanaka N; Satoh K
Int J Oncol; 2016 Sep; 49(3):887-94. PubMed ID: 27572291
[TBL] [Abstract][Full Text] [Related]
34. Semaphorin 3E, an exception to the rule.
Klagsbrun M; Shimizu A
J Clin Invest; 2010 Aug; 120(8):2658-60. PubMed ID: 20664165
[TBL] [Abstract][Full Text] [Related]
35. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
[TBL] [Abstract][Full Text] [Related]
36. Class 3 semaphorins are transcriptionally regulated by 1,25(OH)
Ryynänen J; Kriebitzsch C; Meyer MB; Janssens I; Pike JW; Verlinden L; Verstuyf A
J Steroid Biochem Mol Biol; 2017 Oct; 173():185-193. PubMed ID: 28189595
[TBL] [Abstract][Full Text] [Related]
37. Changes in mRNA expression of class 3 semaphorins and their receptors in the adult rat retino-collicular system after unilateral optic nerve injury.
Sharma A; Pollett MA; Plant GW; Harvey AR
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8367-77. PubMed ID: 23139269
[TBL] [Abstract][Full Text] [Related]
38. Semaphorins in angiogenesis and tumor progression.
Neufeld G; Sabag AD; Rabinovicz N; Kessler O
Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a006718. PubMed ID: 22315716
[TBL] [Abstract][Full Text] [Related]
39. The role of the semaphorins in cancer.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Cell Adh Migr; 2016 Nov; 10(6):652-674. PubMed ID: 27533782
[TBL] [Abstract][Full Text] [Related]
40. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
